コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ified 178 of all 938 patients with permanent hypoparathyroidism.
2 ces the incidence of permanent postoperative hypoparathyroidism.
3 and 30 patients (15.0%) developed persistent hypoparathyroidism.
4 reserve their function and prevent permanent hypoparathyroidism.
5 rgical treatment for permanent postoperative hypoparathyroidism.
6 C) (residue 25 of PTH), which is linked with hypoparathyroidism.
7 perative recurrent laryngeal nerve palsy and hypoparathyroidism.
8 ant decrease in both immediate and permanent hypoparathyroidism.
9 oidism, while 2 patients developed permanent hypoparathyroidism.
10 equire tracheostomy, and 2 had postoperative hypoparathyroidism.
11 emia occurred in the setting of pre-existing hypoparathyroidism.
12 ptides, including drugs for osteoporosis and hypoparathyroidism.
13 s relevant to therapeutic strategies against hypoparathyroidism.
14 , potentially reducing the risk of permanent hypoparathyroidism.
15 rior to TT regarding transient postoperative hypoparathyroidism.
16 was the incidence of transient postoperative hypoparathyroidism.
17 hereas ADH1 is a major cause of non-surgical hypoparathyroidism.
18 nd a therapeutic target for osteoporosis and hypoparathyroidism.
19 y Ca(2+) loss, particularly in patients with hypoparathyroidism.
20 ting correction of both immunodeficiency and hypoparathyroidism.
21 spondylarthropathic changes of long-standing hypoparathyroidism.
22 ed delayed parathyroid AT to treat permanent hypoparathyroidism.
23 tive that results in a very low incidence of hypoparathyroidism.
24 eatening APS-I manifestations such as AI and hypoparathyroidism.
25 a PTH replacement therapy for patients with hypoparathyroidism.
26 id hormone 1-84 (rhPTH[1-84]) in adults with hypoparathyroidism.
27 ta might underestimate the rate of permanent hypoparathyroidism.
28 d to impaired PTH secretion, such as primary hypoparathyroidism.
29 h autosomal dominant and autosomal recessive hypoparathyroidism.
30 DR syndrome and not in one, such as isolated hypoparathyroidism.
31 included and 938 (12.5%) developed permanent hypoparathyroidism.
32 nidentified gene in the etiology of X-linked hypoparathyroidism.
33 hypoplasia, conotruncal cardiac defects, and hypoparathyroidism.
34 roband of an extensive kindred with isolated hypoparathyroidism.
35 pped to 6p23-24, as a candidate for isolated hypoparathyroidism.
36 ssociated with a high incidence of permanent hypoparathyroidism.
37 ns result in autosomal dominant and sporadic hypoparathyroidism.
38 sk for the later development of hypocalcemic hypoparathyroidism.
39 tor mutation in a child with severe sporadic hypoparathyroidism.
40 oidectomy virtually eliminates postoperative hypoparathyroidism.
41 ted RR, 0.1; 95% CI, 0.0-0.4), and permanent hypoparathyroidism (0% vs 1.8%) (weighted RR, 0.2; 95% C
42 ratio [RR], 0.4; 95% CI, 0.2-0.7), temporary hypoparathyroidism (2.2% vs 21.3%) (weighted RR, 0.1; 95
43 tegories of disease, risks were elevated for hypoparathyroidism (2.58; 1.35 to 4.92; p-value 0.004),
48 PS 1), which manifests in a classic triad of hypoparathyroidism, adrenal insufficiency, and candidias
49 udy evaluated the incidence of postoperative hypoparathyroidism after near-total (NTT) versus TT in G
50 Previous data suggest that the incidence of hypoparathyroidism after surgery for Graves disease (GD)
52 In this cohort study, the risk of persistent hypoparathyroidism after total or completion thyroidecto
55 ls from 12 families with autosomal recessive hypoparathyroidism and have investigated them for GCMB a
61 ions of 10p (one patient diagnosed as having hypoparathyroidism and three as DGS) and one patient wit
64 ociated with potential complications such as hypoparathyroidism and vocal cord paralysis in a small p
65 er the second surgery, 2 (25%) had permanent hypoparathyroidism, and 1 (12.5%) developed inoperable c
66 erized by chronic mucocutaneous candidiasis, hypoparathyroidism, and adrenal insufficiency, but patie
67 like autoimmune adrenal insufficiency (AI), hypoparathyroidism, and chronic mucocutaneous candidiasi
68 nifests as a triad of adrenal insufficiency, hypoparathyroidism, and chronic mucocutaneous infections
72 n the definition and treatment of persistent hypoparathyroidism, and use of uniform evidence-based tr
75 e two kindreds exhibiting X-linked recessive hypoparathyroidism are indeed related and that an identi
77 s, our results, which expand the spectrum of hypoparathyroidism-associated GCMB mutations, help eluci
78 t-effective compared with the usual care for hypoparathyroidism at a large, academic institution.
79 cessive disorder characterized by autoimmune hypoparathyroidism, autoimmune adrenocortical failure, a
80 half-life of parathyroid hormone (PTH), can hypoparathyroidism be diagnosed intraoperatively when re
81 ength of stay (OR, 0.98; 95% CI, 0.98-0.99), hypoparathyroidism/calcium disorder (OR, 1.0; 95% CI, 0.
84 emia type 1 (ADH1) is a rare genetic form of hypoparathyroidism caused by gain-of-function (GoF) vari
85 me of the deafness associated with the human hypoparathyroidism, deafness and renal anomaly (HDR) syn
86 ur work indicates that hearing loss in human hypoparathyroidism, deafness and renal anomaly (HDR) syn
87 Human GATA3 haploinsufficiency leads to HDR (hypoparathyroidism, deafness and renal dysplasia) syndro
88 A3 haploinsufficiency also causes human HDR (hypoparathyroidism, deafness, and renal dysplasia) syndr
91 We report on the incidence of persistent hypoparathyroidism, defined as the need for active vitam
92 achieve durable correction of the patients' hypoparathyroidism due to parathyroid graft rejection.
93 ions included seven cases (17%) of permanent hypoparathyroidism; five (71%) of these occurred in grou
96 study (REPLACE), we recruited patients with hypoparathyroidism (>/= 18 months duration) aged 18-85 y
97 caemic (subclinical) hyperparathyroidism and hypoparathyroidism have a low risk of progression to ove
99 reported the association of papilledema and hypoparathyroidism, However, very rarely, case reports r
100 MC) and multisystem autoimmunity, most often hypoparathyroidism (HP) and adrenal insufficiency (AI).
102 Endocrine disorders such as obesity and hypoparathyroidism, hypervitaminosis A, tetracycline use
103 pe 1 (APS-1), which includes hypothyroidism, hypoparathyroidism, hypoadrenalism, and hypogonadotropic
105 parathyroid glands and exhibit a biological hypoparathyroidism, identifying Gcm2 as a master regulat
106 sease genes-including, for example, X-linked hypoparathyroidism in 3 Mb (6 cM) telomeric to Factor IX
107 d embryology and is responsible for isolated hypoparathyroidism in a subset of patients with this dis
108 Surprisingly, we observed correction of hypoparathyroidism in one patient after thymus transplan
109 nalysis there was a higher risk of permanent hypoparathyroidism in patients with parathyroid autotran
122 stating disorder characterized by congenital hypoparathyroidism, mental retardation, facial dysmorphi
123 c sequencing of individuals with nonsurgical hypoparathyroidism (n = 169) and an in vitro functional
124 o intention-to-treat postoperative transient hypoparathyroidism occurred in 19% (20/103) patients aft
130 cal harm was 2.12 to 5.93 cases of permanent hypoparathyroidism per 100 thyroidectomies and 0.99 to 2
134 tions can cause renal aplasia as part of the hypoparathyroidism, renal dysplasia, deafness (HDR) synd
136 ly, Gata3 loss of function is known to cause hypoparathyroidism, sensorineural deafness and renal dis
137 seases due to GATA-3 deficiency - such as in hypoparathyroidism, sensorineural deafness, and renal (H
138 Haplo-insufficiency of the GATA3 gene causes hypoparathyroidism, sensorineural hearing loss, and rena
139 clinical problems including cardiac defects, hypoparathyroidism, T-cell immunodeficiency and facial d
140 s, conotruncal cardiac defects, hypocalcemic hypoparathyroidism, T-cell mediated immune deficiency, a
141 ns were identified in patients with isolated hypoparathyroidism, thereby indicating that GATA3 abnorm
147 vitamin D postoperatively, whereas permanent hypoparathyroidism was considered when there still was a
151 Ninety eight (45.2%) experienced temporary hypoparathyroidism, while 2 patients developed permanent